Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mar Drugs
Autori principali: Bai, Yibo, Zheng, Junping, Yuan, Xubing, Jiao, Siming, Feng, Cui, Du, Yuguang, Liu, Hongtao, Zheng, Lanyan
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6265870/
https://ncbi.nlm.nih.gov/pubmed/30463189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md16110455
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi